Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population

Tissue Antigens

Volumn 70, Issue 1, 2007, Pages 28-33

  Gomez L M ^a,b   Sanchez E ^b   Ruiz Narvaez, E A ^c   Lopez Nevot M A ^d   Anaya, J M ^a,e   Martin J ^b  

^a Corporación para Investigaciones Biológicas ^*  (Colombia)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Delayed type hypersensitivity; Microsatellite; MIF; Polymorphism; Single nucleotide polymorphism; Tuberculin skin test; Tuberculosis

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; ARTICLE; COLOMBIA; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULIN TEST;

ALLELES; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 22; COLOMBIA; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GEOGRAPHY; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICROSATELLITE REPEATS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34249999778     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00843.x     Document Type: Article

References (34)

1. Raviglione MC, Snider DE. A global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995 : 273 : 220 6.
2. Bernhagen J, Bacher M, Calandra T et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996 : 183 : 277 82.
3. Donnelly SC, Bucala R. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today 1997 : 3 : 502 7.
4. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003 : 3 : 791 800.
5. Bernhagen, Calandra T, Mitchell RA et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature 1993 : 365 : 756 9.
6. Juttner J, Bernhagen J, Metz CN, Rollinghoff M, Buccala R, Gessner A. Macrophage migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-α. J Immunol 1998 : 161 : 2383 90.
7. Yamada G, Shijubo N, Takagi-Takahashi Y et al. Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis. Clin Immunol 2002 : 104 : 123 7.
8. Donn R, Alourfi Z, De Benedetti F et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002 : 46 : 2402 9.
9. Baugh JA, Chitnis S, Donnelly SC et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002 : 3 : 170 6.
10. Sanchez E, Gomez LM, Lopez-Nevot MA et al. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 2006 : 7 : 433 6.
11. Awandare GA, Ouma C, Keller CC et al. A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria. Genes Immun 2006 : 7 : 1 8.
12. Gomez LM, Anaya JM, Martin J. Genetic influence of PTPN22 R620W polymorphism in tuberculosis. Hum Immunol 2006 : 66 : 1242 7.
13. Gomez LM, Camargo JF, Castiblanco J, Ruiz-Narvaez EA, Cadena J, Anaya JM. Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis. Tissue Antigens 2006 : 67 : 290 6.
14. Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 2005 : 32 : 219 24.
15. Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 2003 : 361 : 1871 2.
16. Kim JH, Lee SY, Lee SH et al. NRAMP1 genetic polymorphisms as a risk factor of tuberculosis pleurisy. Int J Tuberc Lung Dis 2003 : 7 : 370 5.
17. Lee E, Holzman RS. Evolution and current use of the tuberculin test. Clin Infect Dis 2002 : 34 : 365 70.
18. Donn RP, Plant D, Jury F et al. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 2004 : 123 : 484 7.
19. Weir BS, Hill WG. Estimating F-statistics. Annu Rev Genet 2002 : 36 : 721 50.
20. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978 : 117 : 621 4.
21. Hill AV. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet 2001 : 2 : 373 400.
22. Bellamy R. Genetic susceptibility to tuberculosis. Clin Chest Med 2005 : 26 : 233 46.
23. Van de Vosse E, Hoeve MA, Ottenhoff TH. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 2004 : 4 : 739 49.
24. Bothamley GH, Beck JS, Schreuder GM et al. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis 1989 : 159 : 549 55.
25. Goldfeld AE, Delgado JC, Thim S et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 279 : 226 8.
26. Bellamy R, Ruwende C, Corrah T et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 179 : 721 4.
27. Bellamy R, Ruwende CR, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP-1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 338 : 640 4.
28. Nishihira J. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J Interferon Cytokine Res 2000 : 20 : 751 62.
29. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994 : 179 : 1895 902.
30. Zhong XB, Leng L, Beitin A et al. Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res 2005 : 33 : e121.
31. Radstake TR, Sweep FC, Welsing P et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005 : 52 : 3020 9.
32. Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphism and susceptibility to inflammatory diseases. Clin Infect Dis 2005 : 41 (Suppl 7 S513 9.
33. Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun 2003 : 4 : 4 11.
34. Goldstein DB, Weale ME. Population genomics: linkage disequilibrium holds the key. Curr Biol 2001 : 11 : 576 9.